ArticleFrontiers in oncology2025

Circulating free DNA as a predictive biomarker for response to nivolumab and platinum-based chemotherapy in metastatic esophageal adenocarcinoma: a prospective pilot study.

Qing Sheng Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.